New COVID Variant 'XE'

A warning has been issued against a new mutant 'XE' variant of Omicron by the World Health Organization. XE variant may be more transmissible than any strain of Covid-19 seen before.

According to reports, the new variant is 10 per cent more transmissible than the BA.2 subvariant, which is already the most contagious. As per the WHO, BA.2, which is a subvariant of the Omicron strain, is the most dominant strain of the virus, being 86 per cent of all sequenced cases attributed to it.

Nanobodies That Nullify COVID-19 Variants Identified
The discovery of multiple nanobodies that effectively blocked infection with different COVID-19 variants could pave the way for new treatments.

‘This new variant is a recombinant strain, meaning it is a mutant hybrid of the two previous versions of the Omicron variant, BA.1 and BA.2, which spread across the world when it first became a variant of concern.’

While XE only accounts for a small fraction of the cases, its extremely high transmissibility could mean that it becomes the most dominant strain in the near future.

The WHO has recently issued a report outlining their initial findings of this potentially new variant of concern.

"The XE recombinant (BA.1-BA.2), was first detected in the UK on January 19 and less than 600 sequences have been reported and confirmed since," the report said.

COVID-19 Variant Omicron Blocks the Evading Virus
A new study suggests that people who have been vaccinated against or exposed to the original strain of COVID-19 might produce an immune response to omicron.

"Early-day estimates indicate a community growth rate advantage of 10 percent as compared to BA.2, however, this finding requires further confirmation," it added.

The global health body noted that until they can detect "significant differences in transmission and disease characteristics, including severity", XE will remain categorised as a part of the Omicron variant.

Infection With One COVID-19 Variant Doesn't Protect from Others
Infection by one variant does not provide protection from the other variants, Indian Council of Medical Research Director General Dr Balram Bhargava.

"WHO continues to closely monitor and assess the public health risk associated with recombinant variants, alongside other SARS-CoV-2 variants, and will provide updates as further evidence becomes available," the report continued.

Source-IANS

COVID-19 Variants Have Potential to Escape Immune Response
Various strains of existing SARS-CoV-2 and also future variants that could arise, have the potential to escape the immune system’s cytotoxic T cell response.